Abdominal Pain
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Sign or Symptom
|
302
|
18
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
ABO incompatibility
|
disease |
Immune System Diseases; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
14
|
2
|
0.010 |
None |
1.000 |
1 |
1
|
2016 |
2016 |
Adenolymphoma
|
disease |
Neoplasms
|
Neoplastic Process
|
21
|
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Adenoma
|
group |
Neoplasms
|
Neoplastic Process
|
1183
|
103
|
0.030 |
None |
0.333 |
3 |
3
|
2005 |
2012 |
Adenoma of large intestine
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
452
|
213
|
0.040 |
None |
1.000 |
4 |
2
|
2005 |
2012 |
alpha-Thalassemia
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
86
|
37
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
alpha^+^ Thalassemia
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
92
|
16
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Anemia, Sickle Cell
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
434
|
138
|
0.120 |
None |
1.000 |
3 |
2
|
2004 |
2012 |
Asthma
|
disease |
Respiratory Tract Diseases; Immune System Diseases
|
Disease or Syndrome
|
2096
|
1536
|
0.010 |
None |
1.000 |
1 |
1
|
2009 |
2009 |
Asthma, Aspirin-Induced
|
disease |
Respiratory Tract Diseases; Immune System Diseases; Chemically-Induced Disorders
|
Disease or Syndrome
|
25
|
6
|
0.010 |
None |
1.000 |
1 |
|
2003 |
2003 |
Autoimmune hepatitis type 2
|
disease |
|
Disease or Syndrome
|
16
|
|
0.010 |
None |
1.000 |
1 |
|
1994 |
1994 |
Benign Prostatic Hyperplasia
|
disease |
Male Urogenital Diseases
|
Disease or Syndrome
|
770
|
91
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
beta Thalassemia
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
198
|
103
|
0.030 |
None |
1.000 |
3 |
|
1997 |
2009 |
beta^+^ Thalassemia
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
156
|
44
|
0.020 |
None |
1.000 |
2 |
|
1997 |
2008 |
Biliary calculi
|
phenotype |
Pathological Conditions, Signs and Symptoms; Digestive System Diseases
|
Body Substance
|
48
|
31
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Bilirubin level result
|
phenotype |
|
Laboratory or Test Result
|
32
|
478
|
0.100 |
None |
1.000 |
6 |
151
|
2009 |
2013 |
Bilirubin measurement
|
phenotype |
|
Laboratory Procedure
|
56
|
535
|
0.100 |
None |
1.000 |
13 |
161
|
2009 |
2019 |
BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1
|
phenotype |
|
Finding
|
9
|
3
|
0.100 |
None |
|
0 |
3
|
|
|
Bladder Neoplasm
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
2130
|
281
|
0.010 |
None |
1.000 |
1 |
1
|
2010 |
2010 |
Blood Protein Measurement
|
phenotype |
|
Laboratory Procedure
|
1156
|
2575
|
0.100 |
None |
1.000 |
2 |
4
|
2018 |
2018 |
Breast Carcinoma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
6776
|
2793
|
0.010 |
None |
1.000 |
1 |
2
|
2011 |
2011 |
Carcinogenesis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6243
|
355
|
0.030 |
None |
0.667 |
3 |
|
2006 |
2012 |
Carcinoma
|
group |
Neoplasms
|
Neoplastic Process
|
2462
|
103
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Carcinoma of bladder
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
2104
|
309
|
0.010 |
None |
1.000 |
1 |
1
|
2010 |
2010 |
Carcinoma of lung
|
disease |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
4081
|
1204
|
0.020 |
None |
1.000 |
2 |
4
|
1998 |
2012 |